Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
Annalise Enterprise CTB
Annalise Enterprise CTB
annalise.ai
Annalise Enterprise CTB is an AI clinical decision-support solution for non-contrast head CT, detecting up to 130 findings.
Features include:
• customisable, interactive viewer that integrates into PACS/RIS
• a confidence bar displaying the likelihood of the finding and uncertainty of the AI model
• worklist triage
**FDA 510(k) clearance as CADt for seven acute findings: acute subdural/epidural hematoma, acute subarachnoid hemorrhage, Intra-axial hemorrhage, intraventricular hemorrhage, obstructive hydrocephalus, vasogenic edema, and mass effect.**
Information source:
Vendor
Last updated:
July 9, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
Annalise Enterprise CTB
Company
annalise.ai
Subspeciality
Neuro
Modality
CT
Disease targeted
130 findings present in the emergent, urgent, and non-urgent care settings including: Intracranial haemorrhage, haematomas (acute subdural/extradural), fractures, pneumocephalus, infarct, mass effect & midline shift, obstructive hydrocephalus, Intraaxial mass, transependymal oedema, colloid cyst, vasogenic oedema, and many others.
Key-features
Detection of up to 130 findings (acute and chronic) on brain CT, worklist triage, notification, visualisation, confidence bar, normal/abnormal differentiation
Suggested use
Before: adapting worklist order, flagging acute findings
During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)
Technical Specifications
Data characteristics
Population
All non-contrast head CT studies for patients over 18 years of age
Input
Non-contrast CT
Input format
DICOM
Output
Indication of presence of finding, segmentation overlay, confidence and threshold score/bar
Output format
Customizable AI Viewer. DICOM SC. Worklist – HL7 or API based output for worklist triage (prioritisation)
Technology
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis
Automatically, right after the image acquisition
Processing time
1 - 10 minutes
Regulatory
Certification
CE
Certified, Class IIb
, MDR
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
Annalise Enterprise is a medical device intended to assist clinicians with the interpretation of radiological imaging studies and provide notification of suspected findings.
Market
Market presence
On market since
07-2022
Distribution channels
Nuance PIN, Sectra Amplifier, Blackford
Countries present (clinical, non-research use)
40+
Paying clinical customers (institutes)
300+
Research/test users (institutes)
10+
Pricing
Pricing model
Subscription
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Evaluation of an artificial intelligence model for identification of mass effect and vasogenic edema on computed tomography of the head
(read)
Effects of a comprehensive brain computed tomography deep learning model on radiologist detection accuracy
(read)
Non-peer reviewed papers on performance
Other relevant papers